Sun Pharmaceutical Industries Limited- Madhuranthagam
Form 483 issued February 17, 2023 · Chengalpattu, India
- Observations
- 1
- Pages
- 1
- FEI number
- 3007627683
In short: On February 17, 2023, FDA issued a Form 483 with 1 observation to Sun Pharmaceutical Industries Limited- Madhuranthagam in Chengalpattu, Tamil Nadu (FEI 3007627683). Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).
At a glance
1 of 1 observations on this 483 concern laboratory controls.
Most cited: 21 CFR 211.160 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Laboratory testing is not…
This inspection in context
Questions about this 483
What did FDA find at Sun Pharmaceutical Industries Limited- Madhuranthagam?
FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.
When was Sun Pharmaceutical Industries Limited- Madhuranthagam inspected by FDA?
This Form 483 is dated February 17, 2023.
How do I get the full Form 483 for Sun Pharmaceutical Industries Limited- Madhuranthagam?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.